FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems - FDA Press Releases

FDA permits marketing of first medical device to use artificial intelligence to detect greater than a mild level of diabetic retinopathy in the eye of adults who have diabetes.

from Food and Drug Administration--Press Releases https://ift.tt/2Hhyeg0
via IFTTT